Learn More
MilliporeSigma™ Calbiochem™ Ack1 Inhibitor, AIM-100
A cell-permeable furopyrimidine that acts as a potent, ATP-binding site-targeting, Ack1-selective inhibitor (IC50 = 22nM) and effectively prevents receptor-mediated Ack1 activation (by >90% in MEF & LAPC4 cultures; 16 h 800nM), while exhibiting much reduced potency against Lyn, Lck, Abl1 and BTK (IC50
Supplier: MilliporeSigma™ 10483310MG
Description
A cell-permeable furopyrimidine that acts as a potent, ATP-binding site-targeting, Ack1-selective inhibitor (IC50 = 22nM) and effectively prevents receptor-mediated Ack1 activation (by >90% in MEF & LAPC4 cultures; 16 h 800nM), while exhibiting much reduced potency against Lyn, Lck, Abl1 and BTK (IC50 ≥346.7nM) and no inhibitory activity toward 25 other kinases. Shown to completely inhibit EGF-induced, but not androgen DHT- (dihydrotestosterone) stimulated, AR transcription activity in serum- and androgen-deprived prostate cancer LAPC4 cutlures. Effectively inhibits androgen-independent LNCaP prostate cancer growth both in vitro (by 60%; 72 h 8μM) and in castrated mice in vivo (4mg/kg/96 h injections on day 7/11/15/19/23/27 post tumor transplant).Specifications
10 mg | |
Avoid Freeze-Thaw Cycles, Protect from Light | |
98% by Chiral HPLC, Enantiomeric excess (ee): 98.29% (based on the ee of (S)-(+)-Tetrahydrofurfurylamine, as determined using Chiral HPLC column) | |
873305-35-2 | |
371.4g/mol |
Solid | |
Yellow | |
Ack1 | |
C23H21N3O2 | |
DMSO |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.